1. Home
  2. EEIQ vs LYRA Comparison

EEIQ vs LYRA Comparison

Compare EEIQ & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EEIQ
  • LYRA
  • Stock Information
  • Founded
  • EEIQ 2017
  • LYRA 2005
  • Country
  • EEIQ United States
  • LYRA United States
  • Employees
  • EEIQ N/A
  • LYRA N/A
  • Industry
  • EEIQ Other Consumer Services
  • LYRA Medical/Dental Instruments
  • Sector
  • EEIQ Real Estate
  • LYRA Health Care
  • Exchange
  • EEIQ Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • EEIQ 10.7M
  • LYRA 11.8M
  • IPO Year
  • EEIQ 2021
  • LYRA 2020
  • Fundamental
  • Price
  • EEIQ $0.72
  • LYRA $0.18
  • Analyst Decision
  • EEIQ
  • LYRA Buy
  • Analyst Count
  • EEIQ 0
  • LYRA 5
  • Target Price
  • EEIQ N/A
  • LYRA $4.50
  • AVG Volume (30 Days)
  • EEIQ 37.1K
  • LYRA 917.5K
  • Earning Date
  • EEIQ 03-25-2025
  • LYRA 04-29-2025
  • Dividend Yield
  • EEIQ N/A
  • LYRA N/A
  • EPS Growth
  • EEIQ N/A
  • LYRA N/A
  • EPS
  • EEIQ N/A
  • LYRA N/A
  • Revenue
  • EEIQ $8,153,546.00
  • LYRA $1,471,000.00
  • Revenue This Year
  • EEIQ N/A
  • LYRA N/A
  • Revenue Next Year
  • EEIQ N/A
  • LYRA N/A
  • P/E Ratio
  • EEIQ N/A
  • LYRA N/A
  • Revenue Growth
  • EEIQ 42.73
  • LYRA 3.37
  • 52 Week Low
  • EEIQ $0.60
  • LYRA $0.16
  • 52 Week High
  • EEIQ $1.22
  • LYRA $6.79
  • Technical
  • Relative Strength Index (RSI)
  • EEIQ 34.06
  • LYRA 38.18
  • Support Level
  • EEIQ $0.76
  • LYRA $0.18
  • Resistance Level
  • EEIQ $0.86
  • LYRA $0.20
  • Average True Range (ATR)
  • EEIQ 0.09
  • LYRA 0.01
  • MACD
  • EEIQ -0.01
  • LYRA -0.00
  • Stochastic Oscillator
  • EEIQ 2.32
  • LYRA 0.00

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: